Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Dynavax Technologies (DVAX)

19.7 -0.4 (-1.99%)

04-18 16:00

Open:

20.1

Pre. Close:

20.1

High:

20.55

Low:

19.6

Volume:

1,553,452

Market Cap:

1215M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

20.576 - 20.676

20.676 - 20.775

Low:

19.312 - 19.435

19.435 - 19.556

Close:

19.473 - 19.667

19.667 - 19.859

Technical analysis  (as of: 2018-04-18 4:39:45 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 26.63     One year: 31.10

Support:

Support1: 18.66    Support2: 16.10

Resistance:

Resistance1: 22.80    Resistance2: 26.63

Pivot:

19.43

Moving Averages:

MA(5): 19.83     MA(20): 19.30

MA(100): 17.89     MA(250): 15.59

MACD:

MACD(12,26): 0.56     Signal(12,26,9): 0.56

%K %D:

%K(14,3): 35.64     %D(3): 45.04

RSI:

RSI(14): 55.17

52-Week:

High: 24.45  Low: 5.15  Change(%): 251.8

Average Vol(K):

3-Month: 153200  10-Days 192119

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
DVAX has closed below upper band by 39.9%. Bollinger Bands are 16.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-18T08:00:00-04:00
Your Daily Pharma Scoop: GW Pharmaceuticals' Epidiolex, Alnylam Data, Johnson & Johnson's Q1 Results

2018-04-18T06:21:19-04:00
Dynavax: Positive Results, Market Confusion

2018-04-17T11:46:21-04:00
JF's Core Biotech Buys #11: Positive News For Several Holdings, A Change To Benchmarks And Introducing Our 17th Position

2018-04-16T15:40:18-04:00
Dynavax Tech's lead candidate combined with Keytruda shows positive action in early-stage studies

2018-04-16T12:05:10-04:00
Biotech Forum: The Week Ahead

2018-04-16T09:17:00-04:00
Premarket Gainers as of 9:05 am (04/16/2018)

2018-04-16T07:58:17-04:00
Investors bullish on early-stage data on Dyanvax's SD-101 + Keytruda in advanced melanoma; shares up 14% premarket

2018-04-16T07:50:03-04:00
Dynavax SD-101: Right Drug In The Wrong Combo

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

61.68

Shares Float (M)

60.18

% Held by Insiders

2.40

% Held by Institutions

69.50

Shares Short (K)

6681

Shares Short Prior Month (K)

7630

Stock Financials

EPS

-1.780

EPS Est. Current Year

-1.630

EPS Est. Next Year

-1.540

EPS Est. Next Quarter

-0.170

Forward EPS

-0.490

Book Value (p.s.)

6.100

PEG Ratio

Profit Margin

Operating Margin

-28508.26

Return on Assets (ttm)

-57.9

Return on Equity (ttm)

-65.9

Qtrly Rev. Growth

-99.7

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.065

Qtrly Earnings Growth

Operating Cash Flow (M)

-77.52

Levered Free Cash Flow (M)

-39.01

atoplab.com

Valuation

P/E

-11.07

P/E Growth Ratio

-0.02

P/BV

3.23

P/S

121509609472.00

P/CF

-15.67

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2014-11-10

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.